Sustained viral suppression at 12 months (defined as within 2–18 months) for those eligible for ACs in the enrolled cohort and DiD analysis*.

Sustained viral suppression at 12 months (defined as within 2–18 months) for those eligible for ACs in the enrolled cohort and DiD analysis*.入组队列中符合抗凝血剂（Anticoagulants, ACs）适用指征且参与双重差分（Difference-in-Differences, DiD）分析*的受试者，其12个月时的持续病毒学抑制（该指标定义为随访时间处于2至18个月区间内）。